213 related articles for article (PubMed ID: 28542447)
1. Exploratory plasma proteomic analysis in a randomized crossover trial of aspirin among healthy men and women.
Wang X; Shojaie A; Zhang Y; Shelley D; Lampe PD; Levy L; Peters U; Potter JD; White E; Lampe JW
PLoS One; 2017; 12(5):e0178444. PubMed ID: 28542447
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Aspirin Reduces Plasma Concentrations of the Oncometabolite 2-Hydroxyglutarate: Results of a Randomized, Double-Blind, Crossover Trial.
Liesenfeld DB; Botma A; Habermann N; Toth R; Weigel C; Popanda O; Klika KD; Potter JD; Lampe JW; Ulrich CM
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):180-7. PubMed ID: 26585118
[TBL] [Abstract][Full Text] [Related]
4. The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients.
Petrera M; Paleari L; Clavarezza M; Puntoni M; Caviglia S; Briata IM; Oppezzi M; Mislej EM; Stabuc B; Gnant M; Bachleitner-Hofmann T; Roth W; Scherer D; Haefeli WE; Ulrich CM; DeCensi A
BMC Cancer; 2018 Dec; 18(1):1210. PubMed ID: 30514262
[TBL] [Abstract][Full Text] [Related]
5. Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations.
Nan H; Morikawa T; Suuriniemi M; Imamura Y; Werner L; Kuchiba A; Yamauchi M; Hunter DJ; Kraft P; Giovannucci EL; Fuchs CS; Ogino S; Freedman ML; Chan AT
J Natl Cancer Inst; 2013 Dec; 105(24):1852-61. PubMed ID: 24317174
[TBL] [Abstract][Full Text] [Related]
6. ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial.
Drew DA; Chin SM; Gilpin KK; Parziale M; Pond E; Schuck MM; Stewart K; Flagg M; Rawlings CA; Backman V; Carolan PJ; Chung DC; Colizzo FP; Freedman M; Gala M; Garber JJ; Huttenhower C; Kedrin D; Khalili H; Kwon DS; Markowitz SD; Milne GL; Nishioka NS; Richter JM; Roy HK; Staller K; Wang M; Chan AT
Trials; 2017 Feb; 18(1):50. PubMed ID: 28143522
[TBL] [Abstract][Full Text] [Related]
7. Proteomic Analysis of Plasma Reveals Fat Mass Influences Cancer-Related Pathways in Healthy Humans Fed Controlled Diets Differing in Glycemic Load.
Garrison CB; Zhang Y; Navarro SL; Randolph TW; Hullar MAJ; Kratz M; Neuhouser ML; Raftery D; Lampe PD; Lampe JW
Cancer Prev Res (Phila); 2019 Sep; 12(9):567-578. PubMed ID: 31266826
[TBL] [Abstract][Full Text] [Related]
8. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
[TBL] [Abstract][Full Text] [Related]
9. Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose.
Ruffin MT; Krishnan K; Rock CL; Normolle D; Vaerten MA; Peters-Golden M; Crowell J; Kelloff G; Boland CR; Brenner DE
J Natl Cancer Inst; 1997 Aug; 89(15):1152-60. PubMed ID: 9262254
[TBL] [Abstract][Full Text] [Related]
10. Effect of aspirin on the Wnt/beta-catenin pathway is mediated via protein phosphatase 2A.
Bos CL; Kodach LL; van den Brink GR; Diks SH; van Santen MM; Richel DJ; Peppelenbosch MP; Hardwick JC
Oncogene; 2006 Oct; 25(49):6447-56. PubMed ID: 16878161
[TBL] [Abstract][Full Text] [Related]
11. Magnesium supplementation, metabolic and inflammatory markers, and global genomic and proteomic profiling: a randomized, double-blind, controlled, crossover trial in overweight individuals.
Chacko SA; Sul J; Song Y; Li X; LeBlanc J; You Y; Butch A; Liu S
Am J Clin Nutr; 2011 Feb; 93(2):463-73. PubMed ID: 21159786
[TBL] [Abstract][Full Text] [Related]
12. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
[TBL] [Abstract][Full Text] [Related]
13. Exercise timing influences multi-tissue metabolome and skeletal muscle proteome profiles in type 2 diabetic patients - A randomized crossover trial.
Savikj M; Stocks B; Sato S; Caidahl K; Krook A; Deshmukh AS; Zierath JR; Wallberg-Henriksson H
Metabolism; 2022 Oct; 135():155268. PubMed ID: 35908579
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
Trials; 2013 Jul; 14():237. PubMed ID: 23895505
[TBL] [Abstract][Full Text] [Related]
15. Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC).
Burn J; Mathers J; Bishop DT
Recent Results Cancer Res; 2013; 191():157-83. PubMed ID: 22893205
[TBL] [Abstract][Full Text] [Related]
16. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.
Cook NR; Lee IM; Gaziano JM; Gordon D; Ridker PM; Manson JE; Hennekens CH; Buring JE
JAMA; 2005 Jul; 294(1):47-55. PubMed ID: 15998890
[TBL] [Abstract][Full Text] [Related]
17. Low-dose aspirin and incidence of colorectal tumors in a randomized trial.
Gann PH; Manson JE; Glynn RJ; Buring JE; Hennekens CH
J Natl Cancer Inst; 1993 Aug; 85(15):1220-4. PubMed ID: 8331682
[TBL] [Abstract][Full Text] [Related]
18. Effect of a Single Aspirin Dose Prior to Fecal Immunochemical Testing on Test Sensitivity for Detecting Advanced Colorectal Neoplasms: A Randomized Clinical Trial.
Brenner H; Calderazzo S; Seufferlein T; Ludwig L; Dikopoulos N; Mangold J; Böck W; Stolz T; Eisenbach T; Block T; Kopp-Schneider A; Czock D; Tikk K
JAMA; 2019 May; 321(17):1686-1692. PubMed ID: 31063574
[TBL] [Abstract][Full Text] [Related]
19. Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas.
Passarelli MN; Barry EL; Zhang D; Gangar P; Rees JR; Bresalier RS; McKeown-Eyssen G; Karagas MR; Baron JA
Br J Dermatol; 2018 Aug; 179(2):337-344. PubMed ID: 29570772
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of aspirin and clopidogrel versus aspirin and placebo on markers of smooth muscle proliferation before and after peripheral angioplasty.
Wilson AM; Brittenden J; Bachoo P; Ford I; Nixon GF
J Vasc Surg; 2009 Oct; 50(4):861-9. PubMed ID: 19786240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
